Kheiron Medical Technologies

Kheiron Medical Technologies is an applied science company founded in 2016, based in London, UK, with operations in the United States and Europe. The company specializes in artificial intelligence and machine learning solutions aimed at enhancing cancer diagnostics, particularly for breast cancer patients. Kheiron's mission is to support radiologists in improving patient outcomes, ensuring that technology complements medical professionals rather than replacing them.

The company's primary product, Mia®, is an AI platform designed to assist radiologists in detecting breast cancer earlier and more accurately. Mia® functions as an AI-enabled independent reader for screening mammograms and has received CE regulatory clearance. Additionally, Kheiron offers RSViP™, a tool that optimizes scheduling for women at the highest risk of developing breast cancer. Kheiron collaborates with various healthcare organizations, including NHS trusts and universities, to expand its reach and integrate AI into breast screening programs globally.